tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Similar Stocks

Compare
817 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
VistaGen Therapeutics
$2.85
$84.71M
-42.07%
2 Buy
0 Hold
0 Sell
Moderate Buy
ACADIA Pharmaceuticals
$19.67
$3.28B
25.46
-20.91%
5 Buy
5 Hold
0 Sell
Moderate Buy
Neurocrine
$114.26
$11.36B
34.72
-12.54%
17 Buy
5 Hold
0 Sell
Strong Buy
Intra-Cellular Therapies
$128.60
$13.59B
75.49%
5 Buy
9 Hold
0 Sell
Moderate Buy
SAGE Therapeutics
$7.04
$441.43M
-68.29%
2 Buy
14 Hold
0 Sell
Hold
Axsome Therapeutics
$126.96
$6.21B
54.62%
18 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
VTGN
VistaGen Therapeutics
2.85
-1.97
-40.87%
ACAD
ACADIA Pharmaceuticals
19.67
-5.20
-20.91%
NBIX
Neurocrine
114.26
-16.39
-12.54%
ITCI
Intra-Cellular Therapies
128.60
55.32
75.49%
SAGE
SAGE Therapeutics
7.04
-15.16
-68.29%
AXSM
Axsome Therapeutics
126.96
44.85
54.62%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis